- ADC Therapeutics: Stock rated New Outperform at RBC; PT $33
- AMC : MoffettNathanson adjusts price target to $57 from $55, maintains neutral rating
- AMD: BMO Capital Markets raised the recommendation to market perform from underperform. PT inches down 0.1% to $110
- AstraZeneca: Morgan Stanley reiterates its Overweight rating with a target of GBp 9800.
- Darden: Evercore ISI downgrades to inline from outperform. PT up 7.1 % to $155
- Duke Energy: Vertical Research Partners cut the recommendation to hold from buy. PT up 2.8% to $110
- Greggs: Berenberg remains Buy with target raised from GBp 2950 to GBp 3300
- HP Inc: Reinstated Hold at Jefferies; PT $31
- Mondi: Jefferies remains Buy with a target raised from GBp 2225 to GBp 2300
- ResMed Reinstated Overweight at Wilsons; PT $435.03
- Roku : Pivotal Research lifts price target to $410 from $350, hold rating kept
- Standard Chartered: Jefferies remains Buy with a price target raised from GBp 610 to GBp 736.
- Tesla: Jefferies raised the recommendation to buy from hold. PT up 22% to $850